Equity

Unrealized Gains on Investments

Over 4 years (FY 2020 to FY 2024), Unrealized Gains on Investments shows a downward trend with a -100.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalHigher is better
VolatilityVolatile
First reportedQ3 2018
Last reportedQ4 2025

How to read this metric

Rising gains indicate strong performance of the underlying securities, whereas falling gains reflect market headwinds.

Detailed definition

This metric tracks the total positive difference between the fair market value and the amortized cost of investment secu...

Peer comparison

Commonly reported by all major banks; highly sensitive to interest rate fluctuations.

Metric ID: unrealized_gains_on_investments

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$1.00M$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
QoQ Change-100.0%
YoY Change-100.0%
Range$0.00$1.00M
CAGR-100.0%
Avg YoY Growth-100.0%
Median YoY Growth-100.0%

Frequently Asked Questions

What is Amgen's unrealized gains on investments?
Amgen (AMGN) reported unrealized gains on investments of $0.00 in Q3 2025.
What is the long-term trend for Amgen's unrealized gains on investments?
Over 4 years (2020 to 2024), Amgen's unrealized gains on investments has grown at a -100.0% compound annual growth rate (CAGR), from $1.00M to $0.00.
What does unrealized gains on investments mean?
The total market value increase of investment securities that the bank still owns.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.